About peptides – a warning to Lithuanians

The State Drug Control Service has issued a warning concerning the proliferation of substances marketed online, specifically addressing the status of various peptides. Authorities emphasize that the vast majority of peptides sold through the internet and social media platforms are not officially registered as drugs. This lack of formal registration raises significant concerns regarding oversight, as the production methods, quality control, safety profiles, and actual effectiveness of these products are not adequately assessed or monitored by responsible governmental bodies.

A major risk associated with these unregulated substances is that many are still undergoing investigation, whether in preclinical stages using cell cultures or in early-stage clinical trials. Consequently, definitive data regarding a safe and effective dosage, potential contraindications, or even established side effects and long-term consequences are often unavailable. Furthermore, the service has noted the concerning trend of these products being actively advertised across social networks, potentially leading consumers to believe they are medically approved treatments.

The public health concern is amplified by the fact that while certain conditions, such as heart failure, are seeing increasing incidence rates, advice on protective measures must be approached with caution when considering unverified supplements. Consumers should be aware that the absence of official drug registration means the product’s safety and efficacy have not been verified through established medical channels.

Topics: #not #peptides #registered

One thought on “About peptides – a warning to Lithuanians

  1. This is a serious warning; people need to be much more careful about unregulated supplements sold online.

Leave a Reply

Your email address will not be published. Required fields are marked *